Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation
- PMID: 8667537
- DOI: 10.1001/jama.276.1.39
Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation
Abstract
Objective: To determine the sensitivity, specificity, and likelihood ratios (LRs) for modern screening mammography by decade of age and mammographic interpretation.
Design: Cross-sectional.
Setting: Nine counties in northern California.
Participants: A total of 26,057 women aged 30 years and older who underwent a total of 41,747 first and subsequent screening mammographic examinations at the Mobile Mammography Screening Program of the University of California, San Francisco, from April 1985 to September 1991.
Measurements: Breast cancer risk profile, 2 standard mammographic views per breast, and follow-up of abnormal and normal mammograms of contacting women's physicians and by linkage to the regional Surveillance, Epidemiology, and End Results tumor registry. False-negative examinations were normal examinations that occurred within 13 months of a diagnosis of invasive breast cancer or ductal carcinoma in situ.
Results: The sensitivity of first screening mammography increased with age: 77.3% for ages 30 to 39 years, 86.7% for ages 40 to 49 years, 93.6% for ages 50 to 59 years, 94.1% for ages 60 to 69 years, and 91.2% for ages 70 years and older (P = .04). Specificity was similar for all ages, ranging from 92.6% to 95.2%. Of all abnormal first screening examinations, 92.9% were reported as "additional evaluation needed." The LRs for that category ranged from 5.2 to 8.8 and did not vary with age. Based on the risk of breast cancer before mammography, which increases with age, the risk of breast cancer after mammography associated with these LRs were 0.01 for ages 30 to 39 years, 0.02 for ages 40 to 49 years, 0.05 for ages 50 to 59 years, 0.07 for ages 60 to 69 years, and 0.07 for ages 70 years and older. The LRs for mammography reported as "suspicious for malignancy" ranged from 88 to 144 and did not vary across age groups. These LRs were associated with a risk of breast cancer about 10 times greater than when mammography was reported as "additional evaluation needed."
Conclusion: Most abnormal first screening mammography are interpreted as "additional evaluation needed" and are associated with LRs of about 7. Given this low LR, the risk of breast cancer after mammography is primarily influenced by a woman's age-specific risk of breast cancer before mammography. The LRs for screening mammography interpreted as "suspicious for malignancy" are high (about 124) and are associated with a substantial increase in the risk of breast cancer irrespective of age, but these interpretations comprise only a small proportion of abnormal mammography.
Comment in
-
Strategies for improving sensitivity of screening mammography for women aged 40 to 49 years.JAMA. 1996 Jul 3;276(1):73-4. JAMA. 1996. PMID: 8667544 No abstract available.
-
Screening mammography and risk of breast cancer.JAMA. 1996 Nov 13;276(18):1470; author reply 1470-1. doi: 10.1001/jama.1996.03540180026019. JAMA. 1996. PMID: 8903255 No abstract available.
Similar articles
-
Effect of age, breast density, and family history on the sensitivity of first screening mammography.JAMA. 1996 Jul 3;276(1):33-8. JAMA. 1996. PMID: 8667536
-
Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.J Natl Cancer Inst. 1997 Jan 1;89(1):76-82. doi: 10.1093/jnci/89.1.76. J Natl Cancer Inst. 1997. PMID: 8978410
-
Positive predictive value of screening mammography by age and family history of breast cancer.JAMA. 1993 Nov 24;270(20):2444-50. JAMA. 1993. PMID: 8230621
-
Outcomes of modern screening mammography.J Natl Cancer Inst Monogr. 1997;(22):105-11. doi: 10.1093/jncimono/1997.22.105. J Natl Cancer Inst Monogr. 1997. PMID: 9709285 Review.
-
Evaluation of abnormal mammography results and palpable breast abnormalities.Ann Intern Med. 2003 Aug 19;139(4):274-84. doi: 10.7326/0003-4819-139-4-200308190-00010. Ann Intern Med. 2003. PMID: 12965983 Review.
Cited by
-
Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography?Front Med (Lausanne). 2024 Aug 9;11:1415940. doi: 10.3389/fmed.2024.1415940. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39185467 Free PMC article. Review.
-
Mammography rescreening among older California women.Health Care Financ Rev. 2001 Summer;22(4):63-75. Health Care Financ Rev. 2001. PMID: 12378782 Free PMC article.
-
Detection of microcalcifications by characteristic magnetic susceptibility effects using MR phase image cross-correlation analysis.Med Phys. 2015 Mar;42(3):1436-52. doi: 10.1118/1.4908009. Med Phys. 2015. PMID: 25735297 Free PMC article.
-
Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors.BMC Med Genomics. 2011 Jul 22;4:61. doi: 10.1186/1755-8794-4-61. BMC Med Genomics. 2011. PMID: 21781289 Free PMC article.
-
Quantitative Histopathology Analysis Based on Label-free Multiphoton Imaging for Breast Cancer Diagnosis and Neoadjuvant Immunotherapy Response Assessment.Int J Biol Sci. 2025 Jan 1;21(1):363-381. doi: 10.7150/ijbs.102744. eCollection 2025. Int J Biol Sci. 2025. PMID: 39744437 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous